Skip to main content

Advertisement

Log in

The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

The use of complementary and alternative medicines (CAM) has been reported to be frequent and increasing in the general population and among cancer survivors. Very few studies have investigated the use of CAM among long-term endometrial cancer survivors. To address this gap in evidence, this qualitative study aimed to understand the use of CAM and factors motivating the use among long-term survivors of endometrial cancer.

Methods

Semi-structured qualitative interviews were conducted with 17 women diagnosed with endometrial cancer 7–10 years previously, to understand their CAM use and its impact on their wellbeing. Thematic analysis was performed by two researchers to extract the most relevant quotes related to CAM products, practices, and practitioners.

Results

All 17 women interviewed used some type of CAM practices, practitioners, or products, specifically 94% concentrated on their diet, 88% focused on their exercise, 59% used a CAM product, 53% visited a CAM practitioner, and 18% used a CAM psychological approach. The main motivators for CAM use included to reduce physical and psychological symptoms, and to stop or reduce medications. Women reported a lack of lifestyle advice from their traditional medical healthcare team which they therefore tried to obtain from other sources.

Conclusions

Our findings suggest CAM practices, practitioners, or products form an important part of women’s healthcare options and are commonly used by long-term endometrial cancer survivors. Our data can be of importance to health care professionals and hospitals, as it reflects an unfulfilled need among cancer survivors that does not currently appear to be met by their traditional healthcare team.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  2. Cramer D (2012) The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am 26(1):1–12. https://doi.org/10.1016/j.hoc.2011.10.009

    Article  PubMed  Google Scholar 

  3. Australian Institute of Health and Welfare (AIHW) (2018) Cancer data in Australia. https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/acim-books. Access to 17 January, 2019

  4. Le Boutillier C, Archer S, Barry C, King A, Mansfield L, Urch C (2019) Conceptual framework for living with and beyond cancer: a systematic review and narrative synthesis. Psychooncology 28(5):948–959

    PubMed  PubMed Central  Google Scholar 

  5. Laskey RA, McCarroll ML, von Gruenigen VE (2016) Obesity-related endometrial cancer: an update on survivorship approaches to reducing cardiovascular death. BJOG 123(2):293–298

    Article  CAS  PubMed  Google Scholar 

  6. Johnson S, Park H, Gross C, Yu J (2018) Use of alternative medicine for cancer and its impact on survival. J Natl Cancer Inst 110(1):121–124. https://doi.org/10.1093/jnci/djx145

    Article  Google Scholar 

  7. Koczwara B, Beatty L (2011) Psychology of complementary care in cancer: motivators, barriers and outcomes. Cancer Forum 35(1):1–4

    Google Scholar 

  8. Truant TL, Porcino AJ, Ross BC, Wong ME, Hilario CT (2013) Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review. J Support Oncol 11(3):105–113

    Article  PubMed  Google Scholar 

  9. Li C, Hansen RA, Chou C, Calderón AI, Qian J (2018) Trends in botanical dietary supplement use among US adults by cancer status: the National Health and Nutrition Examination Survey, 1999 to 2014. Cancer 124(6):1207–1215

    Article  PubMed  Google Scholar 

  10. Steel A, Mcintyre E, Harnett J, Foley H, Adams J, Sibbritt D, Wardle J, Frawley J (2018) Complementary medicine use in the Australian population: results of a nationally-representative cross-sectional survey. Sci Rep 8(1):17325. https://doi.org/10.1038/s41598-018-35508-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Xue C, Zhang A, Lin V, Da Costa C, Story D (2007) Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 13(6):643–650. https://doi.org/10.1089/acm.2006.6355

    Article  PubMed  Google Scholar 

  12. Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D, Clarke S (2010) The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia Pac J Clin Oncol 6(4):342–349. https://doi.org/10.1111/j.1743-7563.2010.01329.x

    Article  PubMed  Google Scholar 

  13. Edwards GV, Aherne NJ, Horsley PJ, Benjamin LC, McLachlan CS, McKay MJ, Shakespeare TP (2014) Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy. Asia Pac J Clin Oncol 10(4):346–353. https://doi.org/10.1111/ajco.12203

    Article  PubMed  Google Scholar 

  14. Kristoffersen AE, Stub T, Salamonsen A, Musial F, Hamberg K (2014) Gender differences in prevalence and associations for use of CAM in a large population study. BMC Complement Altern Med 14:463

    Article  PubMed  PubMed Central  Google Scholar 

  15. Correa-Velez I, Clavarino A, Eastwood H (2005) Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 8(5):953–961

    Article  PubMed  Google Scholar 

  16. River J, McKenzie H, Levy D, Pavlakis N, Back M, Oh B (2018) Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatment. Support Care Cancer 26(6):1791–1797. https://doi.org/10.1007/s00520-017-4021-0

    Article  PubMed  Google Scholar 

  17. Peng W, Adams J, Hickman L, Sibbritt D (2014) Complementary/alternative and conventional medicine use amongst menopausal women: results from the Australian Longitudinal Study on Women’s Health. Maturitas 79(3):340–342. https://doi.org/10.1016/j.maturitas.2014.08.002

    Article  PubMed  Google Scholar 

  18. Markovic M, Manderson L, Wray N, Quinn M (2006) Complementary medicine use by Australian women with gynaecological cancer. Psycho-Oncology 15(3):209–220 https://doi-org.ezproxy.library.uq.edu.au/10.1002/pon.936

    Article  PubMed  Google Scholar 

  19. Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, Kücük Ö et al (2017) A comprehensive definition for integrative oncology. J Natl Cancer Inst Monogr. https://doi.org/10.1093/jncimonographs/lgx012

  20. McLaughlin D, Lui CW, Adams J (2012) Complementary and alternative medicine use among older Australian women--a qualitative analysis. BMC Complement Altern Med 12:34. https://doi.org/10.1186/1472-6882-12-34

    Article  PubMed  PubMed Central  Google Scholar 

  21. Welz AN, Emberger-Klein A, Menrad K (2019) What motivates new, established and long-term users of herbal medicine: is there more than push and pull? BMC Complement Altern Med 19(1):170. https://doi.org/10.1186/s12906-019-2584-7

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gyasi RM, Asante F, Yeboah JY, Abass K, Mensah CM, Siaw LP (2016) Pulled in or pushed out? Understanding the complexities of motivation for alternative therapies use in Ghana. Int J Qual Stud Health Well Being 11:29667. https://doi.org/10.3402/qhw.v11.29667 eCollection 2016

    Article  PubMed  Google Scholar 

  23. Sirois FM, Purc-Stephenson RJ (2008) Consumer decision factors for initial and long-term use of complementary and alternative medicine. Complement Health Pract Rev 13(1):3–19. https://doi.org/10.1177/1533210107310824

    Article  Google Scholar 

  24. Shmueli A, Shuval J (2006) Satisfaction with family physicians and specialists and the use of complementary and alternative medicine in Israel. Evid Based Complement Alternat Med 3(2):273–278. https://doi.org/10.1093/ecam/nel009

    Article  PubMed  PubMed Central  Google Scholar 

  25. Furnham A, Smith C (1988) Choosing alternative medicine: a comparison of the beliefs of patients visiting a general practitioner and a homoeopath. Soc Sci Med 26(7):685–689. https://doi.org/10.1016/0277-9536(88)90060-3

    Article  CAS  PubMed  Google Scholar 

  26. Ganguli SC, Cawdron R, Irvine EJ (2004) Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic? Am J Gastroenterol 99(2):319–326. https://doi.org/10.1111/j.1572-0241.2004.04046.x

    Article  PubMed  Google Scholar 

  27. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4(4):274–286. https://doi.org/10.1177/1534735405282361

    Article  PubMed  Google Scholar 

  28. Janda M, Gebski V, Forder P, Jackson D, Williams G, Obermair A (2006) LACE trial committee. Total laparoscopic versus open surgery for stage 1 endometrial cancer: the LACE randomized controlled trial. Contemp Clin Trials 27(4):353–363

    Article  CAS  PubMed  Google Scholar 

  29. Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T et al (2010) Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol 11(8):772–780. https://doi.org/10.1016/S1470-2045(10)70145-5

    Article  PubMed  Google Scholar 

  30. Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede CD, Pather S, Simcock B, Farrell R, Robertson G, Walker G, Armfield NR, Graves N, McCartney A, Obermair A (2017) Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA 317(12):1224–1233

    Article  PubMed  Google Scholar 

  31. Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101

    Article  Google Scholar 

  32. Bishop F, Yardley L, Lewith G (2007) A systematic review of beliefs involved in the use of complementary and alternative medicine. J Health Psychol 12(6):851–867. https://doi.org/10.1177/1359105307082447

    Article  PubMed  Google Scholar 

  33. Cassileth BR (1999) Alternative and complementary medicine. Separating the wheat from the chaff. Cancer 86(10):1900–1902

    Article  CAS  PubMed  Google Scholar 

  34. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP, North Central Cancer Treatment Group (2005) North central cancer treatment group. Evaluation of shark cartilage in patients with advanced cancer: a north central cancer treatment group trial. Cancer 104(1):176–182

    Article  PubMed  Google Scholar 

  35. Ernst E (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83(4):777–782. https://doi.org/10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O

    Article  CAS  PubMed  Google Scholar 

  36. Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, Charalambous H, Dweikat T, Ghrayeb I, Bar-Sela G, Turker I, Hassan A, Hassan E, Saad B, Nimri O, Kebudi R, Silbermann M (2016) Potential risks associated with traditional herbal medicine use in cancer care: a study of middle eastern oncology health care professionals. Cancer 122(4):598–610

    Article  PubMed  Google Scholar 

  37. Byard RW, Musgrave I, Maker G, Bunce M (2017) What risks do herbal products pose to the Australian community? Med J Aust 206(2):86–90

    Article  PubMed  Google Scholar 

  38. Myers SP, Cheras PA (2004) The other side of the coin: safety of complementary and alternative medicine. Med J Aust 181(4):222–225

    Article  PubMed  Google Scholar 

  39. Velicer CM, Ulrich CM (2008) Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26(4):665–673. https://doi.org/10.1200/JCO.2007.13.5905

    Article  CAS  PubMed  Google Scholar 

  40. Reid R, Steel A, Wardle J, Trubody A, Adams J (2016) Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Complement Altern Med 16:176. https://doi.org/10.1186/s12906-016-1143-8

    Article  PubMed  PubMed Central  Google Scholar 

  41. Duncan M, Moschopoulou E, Herrington E, Deane J, Roylance R, Jones L, Bourke L, Morgan A, Chalder T, Thaha MA, Taylor SC, Korszun A, White PD, Bhui K, SURECAN Investigators (2017) Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors. BMJ Open 7(11):e015860. https://doi.org/10.1136/bmjopen-2017-015860

    Article  PubMed  PubMed Central  Google Scholar 

  42. Monti D, Yang J (2005) Complementary medicine in chronic cancer care. Semin Oncol 32(2):225–231

    Article  PubMed  Google Scholar 

  43. Ernst E (2005) Why alternative medicines are used. Pharm J 275(7357):55

    Google Scholar 

  44. Vincent C, Furnham A (1996) Why do patients turn to complementary medicine? An empirical study. Br J Clin Psychol 35:37–48. https://doi.org/10.1111/j.2044-8260.1996.tb01160.x

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Monika Janda was funded by NHMRC Translating Research into Practice fellowship APP1151021. This project was part of LACE trial which was funded by the Cancer Council Queensland, the Cancer Council New South Wales, the Cancer Council Victoria, and the Cancer Council Western Australia; by project grant 456110 from the National Health and Medical Research Council, project grants 631523 and 1098905 from Cancer Australia, and a Smart health research grant from QLD Health; and funding from the Women and Infants Research Foundation, Royal Brisbane and Women’s Hospital Foundation, Wesley Research Institute, Gallipoli Research Foundation, Gynetech, Tyco Healthcare, Johnson & Johnson Medical, Hunter New England Centre for Gynaecological Cancer, Genesis Oncology Trust, and the Cherish Foundation.

Author information

Authors and Affiliations

Authors

Contributions

Conception and design: MJ, AO

Qualitative interview analysis: SS, LC, MJ

Drafting of manuscript: LC, SS, MJ

Critical revision and final approval of manuscript: All authors

Corresponding author

Correspondence to Monika Janda.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Caughey, L., Sanjida, S., Obermair, A. et al. The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia. Support Care Cancer 28, 5479–5489 (2020). https://doi.org/10.1007/s00520-020-05404-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05404-1

Keywords

Navigation